Sector valuations Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:02 2025-07-14 EDT			5-day change	1st Jan Change
83.67 ^USD	+0.37%		+3.42%	-15.89%

07-14	Merck & Co., Inc. to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill	CI
07-14	Merck & Co advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	Price to Book (N)	PEG (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Dividend Yield (N)	Capi.($)
MERCK & CO., INC.	10.72x	3.79x	0.68x	3.48x	7.51x	8.37x	3.85%	210B
ELI LILLY AND COMPANY	37.59x	27.56x	0.46x	12.4x	28.24x	30.4x	0.74%	718B
JOHNSON & JOHNSON	15.03x	5.04x	0.19x	4.2x	11.56x	12.84x	3.35%	377B
ABBVIE INC.	27.31x	48.87x	0.14x	6.56x	13.72x	14.22x	3.42%	338B
NOVO NORDISK A/S	17.01x	9.6x	1.12x	6.14x	12.26x	13.54x	2.97%	308B
ROCHE HOLDING AG	14.2x	5.41x	0.19x	3.5x	8.59x	9.85x	3.83%	259B
NOVARTIS AG	17.18x	5.11x	0.9x	4.63x	11.23x	12.24x	3.25%	237B
ASTRAZENECA PLC	22.67x	4.93x	0.56x	4.21x	12.19x	13.15x	2.24%	222B
AMGEN INC.	22.71x	18.18x	0.31x	5.81x	11.21x	13.18x	3.23%	160B
PFIZER, INC.	11.82x	1.59x	0.23x	2.93x	7.18x	8.45x	6.74%	144B
GILEAD SCIENCES, INC.	20.59x	6.23x	0.02x	5.27x	9.63x	11.6x	2.9%	139B
VERTEX PHARMACEUTICALS INCORPORATED	31.41x	6.24x	-0.04x	9.38x	19.9x	20.82x	-.--%	121B
SANOFI	11.72x	1.3x	0.21x	2.44x	7.97x	8.72x	4.88%	119B
BRISTOL-MYERS SQUIBB COMPANY	10.91x	4.66x	-0.06x	2.8x	7.54x	8.06x	5.23%	96.34B
GSK PLC	10.02x	3.89x	0.08x	2.22x	6.65x	7.52x	4.56%	77.51B
CHUGAI PHARMACEUTICAL CO., LTD.	25.99x	5.66x	2.07x	8.63x	16.99x	17.77x	3.66%	76.79B
JIANGSU HENGRUI MEDICINE CO., LTD.	50.1x	6.83x	3.53x	11.08x	40.56x	44.27x	0.41%	53.34B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	28.01x	1x	0.22x	2.34x	8.24x	21.72x	4.59%	46.68B
HALEON PLC	21.23x	1.99x	2.09x	3.64x	14.55x	16.43x	1.89%	44.37B
Average	21.38x	8.84x	0.68x	5.35x	13.46x	15.43x	3.25%	197.3B
Weighted average by Cap.	22.50x	13.94x	0.50x	6.33x	14.80x	16.30x	2.9%